Polynovo Ltd
ASX:PNV

Watchlist Manager
Polynovo Ltd Logo
Polynovo Ltd
ASX:PNV
Watchlist
Price: 2.07 AUD 0.49% Market Closed
Market Cap: 1.4B AUD
Have any thoughts about
Polynovo Ltd?
Write Note

Polynovo Ltd
Other Current Liabilities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Polynovo Ltd
Other Current Liabilities Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Other Current Liabilities CAGR 3Y CAGR 5Y CAGR 10Y
Polynovo Ltd
ASX:PNV
Other Current Liabilities
AU$12.1m
CAGR 3-Years
446%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Nanosonics Ltd
ASX:NAN
Other Current Liabilities
AU$12.1m
CAGR 3-Years
35%
CAGR 5-Years
19%
CAGR 10-Years
15%
SDI Ltd
ASX:SDI
Other Current Liabilities
AU$1.7m
CAGR 3-Years
-8%
CAGR 5-Years
4%
CAGR 10-Years
6%
Anteris Technologies Ltd
ASX:AVR
Other Current Liabilities
AU$7.6m
CAGR 3-Years
28%
CAGR 5-Years
8%
CAGR 10-Years
N/A
Ansell Ltd
ASX:ANN
Other Current Liabilities
$74.5m
CAGR 3-Years
-16%
CAGR 5-Years
2%
CAGR 10-Years
-4%
L
Lumos Diagnostics Holdings Ltd
ASX:LDX
Other Current Liabilities
$9.4m
CAGR 3-Years
-28%
CAGR 5-Years
27%
CAGR 10-Years
N/A
No Stocks Found

Polynovo Ltd
Glance View

Market Cap
1.4B AUD
Industry
Health Care

Polynovo Ltd. engages in the provision biodegradable medical devices. The company is headquartered in Melbourne, Victoria and currently employs 122 full-time employees. The Company’s principal activity is the development of medical devices for various applications. The Company’s products include NovoSorb Biodegradable Temporizing Matrix (BTM) and NovoSorb technology. BTM is a man-made synthetic polymer that does not contain any biologic materials. BTM is a skin treatment. NovoSorb is a polymer, which is utilizes for the manufacture of novel medical devices, such as Biocompatible polymers. These biocompatible polymers are designed to support different functions of the body and then biodegrade into by-products that can be absorbed and excreted by the body. The company can be produced in a range of formats with different mechanical and degradation properties. In addition to NovoSorb BTM, they can be used for thermoplastic extrusions, filaments for weaving or knitting and as a solution for spray or dip coatings of other devices.

PNV Intrinsic Value
0.85 AUD
Overvaluation 59%
Intrinsic Value
Price

See Also

What is Polynovo Ltd's Other Current Liabilities?
Other Current Liabilities
12.1m AUD

Based on the financial report for Jun 30, 2024, Polynovo Ltd's Other Current Liabilities amounts to 12.1m AUD.

What is Polynovo Ltd's Other Current Liabilities growth rate?
Other Current Liabilities CAGR 3Y
446%

Over the last year, the Other Current Liabilities growth was 89%. The average annual Other Current Liabilities growth rates for Polynovo Ltd have been 446% over the past three years .

Back to Top